KRAS and neoplasm: Taken together, we found that pharmacological inhibition and gene silencing of GSK3α/β selectively induced apoptosis and inhibited tumor growth of mutant KRas-dependent tumors, which was at least in part mediated by c-Myc and β-catenin.